Phase II trial of intranasal doxepin in patients with chronic migraines

Trial Profile

Phase II trial of intranasal doxepin in patients with chronic migraines

Not stated
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2010

At a glance

  • Drugs Doxepin (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors Winston Pharmaceuticals
  • Most Recent Events

    • 29 Nov 2010 New trial record
    • 23 Nov 2010 Results were presented at the Lazard Capital Markets 7th Annual Healthcare Conference, according to a Wintson Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top